Newly formulated GROWJECT® is bioequivalent to the prior GROWJECT® formulation and causes less injection-associated pain
Released: January 05, 2021 |
Volume 30
Issue 1
Pages 35-40
Yasuko Owada, Yuuka Asano, Takashi Hanada, Hidehito Yasukawa, Mariko Yamaoka, Yoko Mita, Noriyuki Namba
Views: 119